| 摘要 |
The invention relates to a quinazolinamide derivative of formula (l), (see formula I) where R1-R5 and X have meanings indicated in Claim 1, that are HSP90-inhibitors and that can be used for producing a medication for treating illnesses for which the prevention, regulation, and/or modulation of HSP90 plays a role. |
